United Kingdom (UK) Oncology-Cancer Drugs Market (2025-2031) | Competitive Landscape, Share, Companies, Trends, Size & Revenue, Outlook, Growth, Forecast, Analysis, Segmentation, Value, Industry

Market Forecast By Drug Class (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Other Cancers) And Competitive Landscape
Product Code: ETC9950410 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) Oncology-Cancer Drugs Market Outlook
  • Market Size of United Kingdom (UK) Oncology-Cancer Drugs Market, 2024
  • Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) Oncology-Cancer Drugs Market Trend Evolution
  • United Kingdom (UK) Oncology-Cancer Drugs Market Drivers and Challenges
  • United Kingdom (UK) Oncology-Cancer Drugs Price Trends
  • United Kingdom (UK) Oncology-Cancer Drugs Porter's Five Forces
  • United Kingdom (UK) Oncology-Cancer Drugs Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Drug Class for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Chemotherapy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Targeted Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Immunotherapy (Biologic Therapy) for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Hormonal Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Stomach Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Prostate Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Liver Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Esophagus Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume By Other Cancers for the Period 2021- 2031
  • United Kingdom (UK) Oncology-Cancer Drugs Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Indication
  • United Kingdom (UK) Oncology-Cancer Drugs Top Companies Market Share
  • United Kingdom (UK) Oncology-Cancer Drugs Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Oncology-Cancer Drugs Company Profiles
  • United Kingdom (UK) Oncology-Cancer Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Oncology-Cancer Drugs Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Oncology-Cancer Drugs Market - Industry Life Cycle

3.4 United Kingdom (UK) Oncology-Cancer Drugs Market - Porter's Five Forces

3.5 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F

4 United Kingdom (UK) Oncology-Cancer Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United Kingdom (UK) Oncology-Cancer Drugs Market Trends

6 United Kingdom (UK) Oncology-Cancer Drugs Market, By Types

6.1 United Kingdom (UK) Oncology-Cancer Drugs Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F

6.1.4 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F

6.1.5 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F

6.1.6 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F

6.2 United Kingdom (UK) Oncology-Cancer Drugs Market, By Indication

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.2.3 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F

6.2.4 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.2.5 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.2.6 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.2.7 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.2.8 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F

6.2.9 United Kingdom (UK) Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F

7 United Kingdom (UK) Oncology-Cancer Drugs Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Oncology-Cancer Drugs Market Export to Major Countries

7.2 United Kingdom (UK) Oncology-Cancer Drugs Market Imports from Major Countries

8 United Kingdom (UK) Oncology-Cancer Drugs Market Key Performance Indicators

9 United Kingdom (UK) Oncology-Cancer Drugs Market - Opportunity Assessment

9.1 United Kingdom (UK) Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United Kingdom (UK) Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F

10 United Kingdom (UK) Oncology-Cancer Drugs Market - Competitive Landscape

10.1 United Kingdom (UK) Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All